Pharmaceutical

Atantares raises $13.9m in pre-Series A funding to develop molecular chips

Atantares plans to use the $13.9m funding for research and development, service operation, and capacity expansion.

Aug 2, 2023 - 20:00
Atantares raises $13.9m in pre-Series A funding to develop molecular chips
Atantares plans to use the $13.9m funding for research and development, service operation, and capacity expansion.
Read the original article

Tags:

Previous Article

CS Pharmaceuticals snaps up AxeroVision to shore up ophthalmology portfolio

Next Article

FDA warns of reduced efficacy for oral birth control pill Tydemy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Phenomic scores two deals in two days with Boehringer and Astellas 

Phenomic scores two deals in two days with Boehringer a...

Dec 2, 2023

STAT+: Wegovy is usually taken indefinitely. Amgen wants a version that can be tapered down

STAT+: Wegovy is usually taken indefinitely. Amgen want...

Feb 5, 2024

STAT+: Intellia plays down concerns about accidental germline transmission in CRISPR trial

STAT+: Intellia plays down concerns about accidental ge...

Aug 21, 2023